GlassScriptPhysician profile
Debra Anne Bourne
NPI 1215215629
$3,708.21
in general payments reported to CMS, 2019-2025
23 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 85% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
See the full distribution for Surgery of the Hand (Plastic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $435 · 2023: $425 · 2024: $706 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $571.02 | 2024-2025 | Sx-One Microknife |
| Trimed, INC. | $482.50 | 2025 | |
| Abbvie INC. | $449.86 | 2024-2025 | |
| Sientra, INC. | $258.32 | 2021-2022 | |
| Amgen INC. | $251.21 | 2025 | Krystexxa, Tavneos |
| Mentor Worldwide LLC | $208.39 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Integra Lifesciences Corporation | $187.37 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Tezspire |
| Alafair Biosciences, INC. | $111.88 | 2025 | Versawrap |
| Hologic Sales and Service, LLC | $111.88 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Nalu Medical, INC. | $105.34 | 2023 | Nalu Neurostimulation System |
| Acumed LLC | $105.10 | 2024 | Inframe Implant |
| Horizon Therapeutics Plc | $102.76 | 2023 | Tepezza |
| Allergan, INC. | $98.65 | 2022 | |
| Endo Pharmaceuticals INC. | $85.06 | 2023-2024 | Xiaflex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $84.96 | 2022 | |
| Depuy Synthes Sales INC. | $84.87 | 2023 | Matrixcombo |
| Novo Nordisk INC | $83.49 | 2024 | Wegovy |
| Tela Bio, INC. | $69.42 | 2022 | |
| Innovation Technologies INC | $66.32 | 2021 | |
| Endo USA, INC. | $51.31 | 2024-2025 | Xiaflex |
| Orthofix Medical, INC. | $13.50 | 2025 | Accelstim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Bourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.